United Therapeutics CorporationUTHRNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P31
Within normal range
vs 2Y Ago
-2.1x
Contraction
Streak
1 qtr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.69% |
| Q3 2025 | -1.74% |
| Q2 2025 | 1.30% |
| Q1 2025 | 6.35% |
| Q4 2024 | -0.87% |
| Q3 2024 | 4.50% |
| Q2 2024 | 5.34% |
| Q1 2024 | 11.24% |
| Q4 2023 | 0.82% |
| Q3 2023 | 1.30% |
| Q2 2023 | 17.11% |
| Q1 2023 | 4.36% |
| Q4 2022 | -9.02% |
| Q3 2022 | 9.52% |
| Q2 2022 | 0.28% |
| Q1 2022 | 14.56% |
| Q4 2021 | -8.73% |
| Q3 2021 | 1.88% |
| Q2 2021 | 14.94% |
| Q1 2021 | 1.71% |
| Q4 2020 | -1.68% |
| Q3 2020 | 5.95% |
| Q2 2020 | 0.96% |
| Q1 2020 | 17.92% |
| Q4 2019 | -23.39% |
| Q3 2019 | 6.23% |
| Q2 2019 | 4.02% |
| Q1 2019 | -4.58% |
| Q4 2018 | -3.13% |
| Q3 2018 | -5.75% |
| Q2 2018 | 13.93% |
| Q1 2018 | -18.39% |
| Q4 2017 | -3.36% |
| Q3 2017 | 0.07% |
| Q2 2017 | 19.51% |
| Q1 2017 | -6.41% |
| Q4 2016 | -1.04% |
| Q3 2016 | -2.04% |
| Q2 2016 | 6.60% |
| Q1 2016 | -2.97% |